Alx Oncology Holdings (ALXO) Non-cash Items (2019 - 2025)
Alx Oncology Holdings recorded quarterly Non-cash Items of $6.1 million in Q4 2025, up 1388.36% quarter-over-quarter from $409000.0 in Q4 2024, and up 1388.36% year-over-year from $409000.0 in Q4 2024.
Alx Oncology Holdings' Non-cash Items history runs 6 years deep, the most recent figure standing at $6.1 million for Q4 2025.
- In Q4 2025, Non-cash Items rose 1388.36% year-over-year to $6.1 million; the TTM figure through Dec 2025 stood at $6.1 million (up 1388.36% YoY), while the FY2025 annual figure was $6.1 million, up 1388.36% from the prior year.
- Non-cash Items came in at $6.1 million for Q4 2025 at Alx Oncology Holdings, up from $409000.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $59.9 million in Q4 2023 to a low of $409000.0 in Q4 2024.
- A 5-year average of $27.2 million and a median of $19.9 million in 2022 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items sank 99.32% in 2024 and jumped 1388.36% in 2025, its largest moves.
- Alx Oncology Holdings' Non-cash Items stood at $49.7 million in 2021, then tumbled by 60.05% to $19.9 million in 2022, then jumped by 201.43% to $59.9 million in 2023, then tumbled by 99.32% to $409000.0 in 2024, then surged by 1388.36% to $6.1 million in 2025.
- According to Business Quant data, Non-cash Items over the past three periods registered $6.1 million, $409000.0, and $59.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.09 Mn |
| Dec 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 409,000.00 |
| Dec 31, 2024 | 409,000.00 |
| Dec 31, 2023 | 59.90 Mn |
| Dec 31, 2023 | 59.90 Mn |
| Dec 31, 2022 | 19.87 Mn |
| Dec 31, 2022 | 19.87 Mn |
| Dec 31, 2021 | 49.75 Mn |
| Dec 31, 2021 | 49.75 Mn |
| Dec 31, 2019 | 27,000.00 |
| Dec 31, 2019 | 27,000.00 |